Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0001232
UniProt IDQ8WUA4
Primary gene name(s)GTF3C2
Synonym gene name(s)KIAA0011
Protein nameGeneral transcription factor 3C polypeptide 2
Protein functionRequired for RNA polymerase III-mediated transcription. Component of TFIIIC that initiates transcription complex assembly on tRNA and is required for transcription of 5S rRNA and other stable nuclear and cytoplasmic RNAs. May play a direct role in stabilizing interactions of TFIIIC2 with TFIIIC1.
Subcellular locationNucleus.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: Q8WUA4
Gene Ontology
(Biological Process)
Complete annatation
5S class rRNA transcription from RNA polymerase III type 1 promoter [GO:0042791];
transcription, DNA-templated [GO:0006351];
transcription from RNA polymerase III promoter [GO:0006383];
tRNA transcription from RNA polymerase III promoter [GO:0042797]
Gene Ontology
(Molecular Function)
Complete annatation
Gene Ontology
(Cellular Component)
Complete annatation
nucleoplasm [GO:0005654];
transcription factor TFIIIC complex [GO:0000127]
Protein-protein interaction109231
Phylogenetic treeQ8WUA4
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD30.1771111514654050.5886000133535820.694976843029
AZA vs. DISU0.1292141118390710.6094778648273180.956708251005622
AZA vs. IL70.09523330123350970.6207543591132350.999311006273513
AZA vs. SAHA-0.4596635675361010.06159134695719180.304653269352937
DISU vs. CD3-0.06050346329401610.8673045542896970.910543146234564
DISU vs. IL7-0.04314294311964120.8639683930232970.974145458987187
DISU vs. SAHA-0.5868269135514590.04561712566255750.265237538912193
DMSO vs. AZA0.07297867561852990.6637391371647531
DMSO vs. CD3-0.117378966252010.7133809524422170.790750058755206
DMSO vs. DISU-0.05853889490999440.8103401391405780.97872015419905
DMSO vs. IL70.02980575626317180.8684569855833820.970988552033595
DMSO vs. SAHA-0.537983946260680.0234439586960360.157522916410146
HIV vs. Mock in Activation-0.084513275819060.8919739248339620.999983755607037
HIV vs. Mock in Latency0.002930011982392820.9858578475611610.999834320637052
IL7 vs. CD3-0.07495124165665680.8153761942871330.879923185233051
SAHA vs. CD3-0.6605819182085170.06299043623674640.120023501591575
SAHA vs. IL7-0.5577601906491290.02295126550968240.109840020692777
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) FALSE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK 0.039984 0.844803
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
0.92 1.044 1.004 1.011 1.096
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

not found

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

HIV Partner Interaction Type PubMed
Tat activates 1403646

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
not found